Article Versions Notes

Burns EA, Gee K, Kieser RB, Xu J, Zhang Y, Crenshaw A, Muhsen IN, Mylavarapu C, Esmail A, Shah S, et al. Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer. Cancers. 2023; 15(1):81. https://doi.org/10.3390/cancers15010081

Burns, Ethan A., Kelly Gee, Ryan B. Kieser, Jiaqiong Xu, Yuqi Zhang, Aubrey Crenshaw, Ibrahim N. Muhsen, Charisma Mylavarapu, Abdullah Esmail, Shivan Shah, and et al. 2023. "Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer" Cancers 15, no. 1: 81. https://doi.org/10.3390/cancers15010081

Burns, E. A., Gee, K., Kieser, R. B., Xu, J., Zhang, Y., Crenshaw, A., Muhsen, I. N., Mylavarapu, C., Esmail, A., Shah, S., Umoru, G., Sun, K., Guerrero, C., Gong, Z., Heyne, K., Singh, M., Zhang, J., Bernicker, E. H., & Abdelrahim, M. (2023). Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer. Cancers, 15(1), 81. https://doi.org/10.3390/cancers15010081